top of page
© 2021-2024 Marine Pharmacology
Approved Marine Drugs
Last Update: June 6, 2024
NOTE: Clinical trial numbers were updated and may include Phase 3, as well as Phase 2 and Phase 1 if ongoing.
ABBREVIATIONS:
ADC: Antibody Drug Conjugate;
Ara-A: 9-β-D-arabinofuranosyladenine
Ara-C: Cytosine Arabinoside
BCMA: B-cell Maturation Antigen
CD: Cluster of Differentiation;
c-Met: Tyrosine-Protein Kinase Met
DMXBA: 3-(2,4-Dimethoxybenzylidene)-Anabaseine
EGFR: Epidermal Growth Factor Receptor;
ENPP3: Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3
FDA: Food and Drug Administration;
GPNMB: Glycoprotein nonmetastatic B;
LIV-1: Zinc transporter SLC39A6;
LRRC15: Leucine rich repeat containing 15
MMAE: Monomethylauristatin E;
MMAF: Monomethylauristatin F;
NaPi2b: Sodium-Dependent Phosphate Transport Protein 2b;
PSMA: Prostate-Specific Membrane Antigen;
TIM-1: T-cell Immunoglobulin domain 1
© 2021-2024 Marine Pharmacology
bottom of page